SRPT Annual Net Income
-$535.98 M
+$167.51 M+23.81%
31 December 2023
Summary:
As of January 20, 2025, SRPT annual net profit is -$535.98 million, with the most recent change of +$167.51 million (+23.81%) on December 31, 2023. During the last 3 years, it has risen by +$18.15 million (+3.28%). SRPT annual net income is now -25422.71% below its all-time high of -$2.10 million, reached on December 31, 1996.SRPT Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SRPT Quarterly Net Income
$33.61 M
+$27.15 M+420.29%
30 September 2024
Summary:
As of January 20, 2025, SRPT quarterly net profit is $33.61 million, with the most recent change of +$27.15 million (+420.29%) on September 30, 2024. Over the past year, it has dropped by -$12.04 million (-26.38%). SRPT quarterly net income is now -60.03% below its all-time high of $84.09 million, reached on March 31, 2017.SRPT Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SRPT TTM Net Income
$121.84 M
+$74.55 M+157.62%
30 September 2024
Summary:
As of January 20, 2025, SRPT TTM net profit is $121.84 million, with the most recent change of +$74.55 million (+157.62%) on September 30, 2024. Over the past year, it has increased by +$657.82 million (+122.73%). SRPT TTM net income is now at all-time high.SRPT TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SRPT Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.8% | -26.4% | +122.7% |
| 3 y3 years | +3.3% | +113.0% | +117.0% |
| 5 y5 years | -48.1% | +113.0% | +117.0% |
SRPT Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -28.0% | +23.8% | -26.4% | +106.5% | at high | +110.9% |
| 5 y | 5-year | -28.0% | +25.1% | -26.4% | +106.5% | at high | +110.9% |
| alltime | all time | <-9999.0% | +25.1% | -60.0% | +106.5% | at high | +110.9% |
Sarepta Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $33.61 M(+420.3%) | $121.84 M(+157.6%) |
| June 2024 | - | $6.46 M(-82.1%) | $47.30 M(+179.9%) |
| Mar 2024 | - | $36.12 M(-20.9%) | $16.90 M(-103.2%) |
| Dec 2023 | -$535.98 M(-23.8%) | $45.66 M(-211.5%) | -$535.98 M(-22.4%) |
| Sept 2023 | - | -$40.94 M(+71.0%) | -$690.88 M(-23.9%) |
| June 2023 | - | -$23.94 M(-95.4%) | -$907.68 M(-18.6%) |
| Mar 2023 | - | -$516.75 M(+373.0%) | -$1.12 B(+58.5%) |
| Dec 2022 | -$703.49 M(+68.0%) | -$109.24 M(-57.6%) | -$703.49 M(-1.8%) |
| Sept 2022 | - | -$257.74 M(+11.3%) | -$716.23 M(+41.4%) |
| June 2022 | - | -$231.48 M(+120.4%) | -$506.63 M(+42.1%) |
| Mar 2022 | - | -$105.03 M(-13.9%) | -$356.56 M(-14.9%) |
| Dec 2021 | -$418.78 M(-24.4%) | -$121.98 M(+153.4%) | -$418.78 M(-13.9%) |
| Sept 2021 | - | -$48.14 M(-40.9%) | -$486.12 M(-23.4%) |
| June 2021 | - | -$81.41 M(-51.3%) | -$634.47 M(-9.9%) |
| Mar 2021 | - | -$167.25 M(-11.7%) | -$703.89 M(+27.0%) |
| Dec 2020 | -$554.13 M(-22.5%) | -$189.32 M(-3.7%) | -$554.13 M(-7.7%) |
| Sept 2020 | - | -$196.50 M(+30.3%) | -$600.51 M(+13.2%) |
| June 2020 | - | -$150.82 M(+762.2%) | -$530.34 M(-19.1%) |
| Mar 2020 | - | -$17.49 M(-92.6%) | -$655.92 M(-8.3%) |
| Dec 2019 | -$715.08 M(+97.6%) | -$235.70 M(+86.6%) | -$715.08 M(+15.3%) |
| Sept 2019 | - | -$126.33 M(-54.3%) | -$620.27 M(+8.8%) |
| June 2019 | - | -$276.40 M(+260.6%) | -$570.33 M(+41.5%) |
| Mar 2019 | - | -$76.64 M(-45.6%) | -$403.20 M(+11.4%) |
| Dec 2018 | -$361.92 M(+614.0%) | -$140.90 M(+84.4%) | -$361.92 M(+47.7%) |
| Sept 2018 | - | -$76.39 M(-30.1%) | -$245.02 M(+13.2%) |
| June 2018 | - | -$109.27 M(+209.0%) | -$216.36 M(+27.2%) |
| Mar 2018 | - | -$35.36 M(+47.4%) | -$170.14 M(+235.7%) |
| Dec 2017 | -$50.69 M(-81.0%) | -$24.00 M(-49.7%) | -$50.69 M(-56.0%) |
| Sept 2017 | - | -$47.73 M(-24.3%) | -$115.14 M(-7.3%) |
| June 2017 | - | -$63.05 M(-175.0%) | -$124.15 M(+0.6%) |
| Mar 2017 | - | $84.09 M(-195.1%) | -$123.41 M(-53.8%) |
| Dec 2016 | -$267.26 M(+21.5%) | -$88.45 M(+55.9%) | -$267.26 M(+9.8%) |
| Sept 2016 | - | -$56.74 M(-8.9%) | -$243.49 M(+2.0%) |
| June 2016 | - | -$62.30 M(+4.2%) | -$238.69 M(+9.4%) |
| Mar 2016 | - | -$59.77 M(-7.6%) | -$218.24 M(-0.8%) |
| Dec 2015 | -$220.03 M(+62.0%) | -$64.68 M(+24.5%) | -$220.03 M(+10.1%) |
| Sept 2015 | - | -$51.94 M(+24.1%) | -$199.76 M(+12.8%) |
| June 2015 | - | -$41.85 M(-32.0%) | -$177.05 M(+4.7%) |
| Mar 2015 | - | -$61.56 M(+38.6%) | -$169.07 M(+24.5%) |
| Dec 2014 | -$135.79 M(+21.3%) | -$44.42 M(+52.0%) | -$135.79 M(+35.5%) |
| Sept 2014 | - | -$29.23 M(-13.7%) | -$100.19 M(-11.3%) |
| June 2014 | - | -$33.87 M(+19.8%) | -$113.00 M(+15.1%) |
| Mar 2014 | - | -$28.27 M(+220.6%) | -$98.17 M(-12.3%) |
| Dec 2013 | -$111.98 M(-7.7%) | -$8.82 M(-79.0%) | -$111.98 M(-32.2%) |
| Sept 2013 | - | -$42.03 M(+120.6%) | -$165.23 M(-4.4%) |
| June 2013 | - | -$19.05 M(-54.7%) | -$172.76 M(+18.6%) |
| Mar 2013 | - | -$42.08 M(-32.2%) | -$145.67 M(+20.1%) |
| Dec 2012 | -$121.29 M(+5132.4%) | -$62.07 M(+25.3%) | -$121.29 M(+100.0%) |
| Sept 2012 | - | -$49.55 M(-716.5%) | -$60.63 M(+301.6%) |
| June 2012 | - | $8.04 M(-145.4%) | -$15.10 M(-30.9%) |
| Mar 2012 | - | -$17.70 M(+1155.6%) | -$21.86 M(+842.8%) |
| Dec 2011 | -$2.32 M(-92.8%) | -$1.41 M(-64.9%) | -$2.32 M(-72.9%) |
| Sept 2011 | - | -$4.02 M(-414.3%) | -$8.55 M(-27.7%) |
| June 2011 | - | $1.28 M(-30.2%) | -$11.82 M(-60.3%) |
| Mar 2011 | - | $1.83 M(-124.0%) | -$29.76 M(-7.5%) |
| Dec 2010 | -$32.18 M | -$7.64 M(+4.8%) | -$32.18 M(+53.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2010 | - | -$7.29 M(-56.2%) | -$21.01 M(-3.7%) |
| June 2010 | - | -$16.66 M(+2752.1%) | -$21.80 M(-12.1%) |
| Mar 2010 | - | -$584.00 K(-116.6%) | -$24.82 M(-1.4%) |
| Dec 2009 | -$25.16 M(+5.0%) | $3.52 M(-143.6%) | -$25.16 M(-15.6%) |
| Sept 2009 | - | -$8.09 M(-58.9%) | -$29.83 M(+7.4%) |
| June 2009 | - | -$19.67 M(+2021.7%) | -$27.78 M(+181.6%) |
| Mar 2009 | - | -$927.00 K(-18.7%) | -$9.87 M(-58.8%) |
| Dec 2008 | -$23.95 M(-11.8%) | -$1.14 M(-81.1%) | -$23.95 M(-11.1%) |
| Sept 2008 | - | -$6.05 M(+245.3%) | -$26.94 M(-3.5%) |
| June 2008 | - | -$1.75 M(-88.3%) | -$27.93 M(-19.5%) |
| Mar 2008 | - | -$15.02 M(+263.8%) | -$34.71 M(+18.0%) |
| Dec 2007 | -$27.17 M(-12.6%) | -$4.13 M(-41.3%) | -$29.42 M(-12.8%) |
| Sept 2007 | - | -$7.03 M(-17.6%) | -$33.76 M(+2.4%) |
| June 2007 | - | -$8.54 M(-12.2%) | -$32.98 M(+5.2%) |
| Mar 2007 | - | -$9.72 M(+14.9%) | -$31.34 M(+2.2%) |
| Dec 2006 | -$31.07 M(+86.3%) | -$8.46 M(+35.4%) | -$30.68 M(+14.6%) |
| Sept 2006 | - | -$6.25 M(-9.4%) | -$26.77 M(+20.5%) |
| June 2006 | - | -$6.90 M(-23.8%) | -$22.21 M(+9.7%) |
| Mar 2006 | - | -$9.06 M(+99.1%) | -$20.24 M(+21.4%) |
| Dec 2005 | -$16.68 M(-32.7%) | -$4.55 M(+168.9%) | -$16.68 M(-2.6%) |
| Sept 2005 | - | -$1.69 M(-65.7%) | -$17.11 M(-16.6%) |
| June 2005 | - | -$4.93 M(-10.3%) | -$20.53 M(-9.7%) |
| Mar 2005 | - | -$5.50 M(+10.2%) | -$22.74 M(-8.2%) |
| Dec 2004 | -$24.78 M(+69.5%) | -$4.99 M(-2.3%) | -$24.78 M(+8.3%) |
| Sept 2004 | - | -$5.11 M(-28.6%) | -$22.88 M(+2.2%) |
| June 2004 | - | -$7.15 M(-5.1%) | -$22.38 M(+19.5%) |
| Mar 2004 | - | -$7.53 M(+143.3%) | -$18.73 M(+28.1%) |
| Dec 2003 | -$14.62 M(-50.2%) | -$3.10 M(-32.7%) | -$14.62 M(-5.8%) |
| Sept 2003 | - | -$4.60 M(+31.6%) | -$15.51 M(-13.6%) |
| June 2003 | - | -$3.50 M(+2.3%) | -$17.96 M(-28.0%) |
| Mar 2003 | - | -$3.42 M(-14.4%) | -$24.96 M(-15.0%) |
| Dec 2002 | -$29.36 M(+9.0%) | -$3.99 M(-43.4%) | -$29.36 M(-2.0%) |
| Sept 2002 | - | -$7.05 M(-32.8%) | -$29.97 M(-22.2%) |
| June 2002 | - | -$10.50 M(+34.3%) | -$38.51 M(+22.0%) |
| Mar 2002 | - | -$7.82 M(+69.8%) | -$31.56 M(+17.2%) |
| Dec 2001 | -$26.93 M(+191.4%) | -$4.60 M(-70.5%) | -$26.93 M(+6.3%) |
| Sept 2001 | - | -$15.60 M(+339.8%) | -$25.33 M(+111.3%) |
| June 2001 | - | -$3.55 M(+11.6%) | -$11.98 M(+6.3%) |
| Mar 2001 | - | -$3.18 M(+5.7%) | -$11.28 M(+22.1%) |
| Dec 2000 | -$9.24 M(+11.3%) | -$3.01 M(+33.5%) | -$9.24 M(+7.0%) |
| Sept 2000 | - | -$2.25 M(-20.7%) | -$8.63 M(+0.6%) |
| June 2000 | - | -$2.84 M(+149.2%) | -$8.58 M(+10.9%) |
| Mar 2000 | - | -$1.14 M(-52.5%) | -$7.74 M(-6.7%) |
| Dec 1999 | -$8.30 M(-68.9%) | -$2.40 M(+9.1%) | -$8.30 M(0.0%) |
| Sept 1999 | - | -$2.20 M(+10.0%) | -$8.30 M(-69.7%) |
| June 1999 | - | -$2.00 M(+17.6%) | -$27.40 M(+1.1%) |
| Mar 1999 | - | -$1.70 M(-29.2%) | -$27.10 M(+1.1%) |
| Dec 1998 | -$26.70 M(+641.7%) | -$2.40 M(-88.7%) | -$26.80 M(+6.3%) |
| Sept 1998 | - | -$21.30 M(+1152.9%) | -$25.20 M(+425.0%) |
| June 1998 | - | -$1.70 M(+21.4%) | -$4.80 M(+9.1%) |
| Mar 1998 | - | -$1.40 M(+75.0%) | -$4.40 M(+33.3%) |
| Dec 1997 | -$3.60 M(+71.4%) | -$800.00 K(-11.1%) | -$3.30 M(+32.0%) |
| Sept 1997 | - | -$900.00 K(-30.8%) | -$2.50 M(+56.3%) |
| June 1997 | - | -$1.30 M(+333.3%) | -$1.60 M(+433.3%) |
| Mar 1997 | - | -$300.00 K | -$300.00 K |
| Dec 1996 | -$2.10 M | - | - |
FAQ
- What is Sarepta Therapeutics annual net profit?
- What is the all time high annual net income for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual net income year-on-year change?
- What is Sarepta Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly net income year-on-year change?
- What is Sarepta Therapeutics TTM net profit?
- What is the all time high TTM net income for Sarepta Therapeutics?
- What is Sarepta Therapeutics TTM net income year-on-year change?
What is Sarepta Therapeutics annual net profit?
The current annual net income of SRPT is -$535.98 M
What is the all time high annual net income for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual net profit is -$2.10 M
What is Sarepta Therapeutics annual net income year-on-year change?
Over the past year, SRPT annual net profit has changed by +$167.51 M (+23.81%)
What is Sarepta Therapeutics quarterly net profit?
The current quarterly net income of SRPT is $33.61 M
What is the all time high quarterly net income for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly net profit is $84.09 M
What is Sarepta Therapeutics quarterly net income year-on-year change?
Over the past year, SRPT quarterly net profit has changed by -$12.04 M (-26.38%)
What is Sarepta Therapeutics TTM net profit?
The current TTM net income of SRPT is $121.84 M
What is the all time high TTM net income for Sarepta Therapeutics?
Sarepta Therapeutics all-time high TTM net profit is $121.84 M
What is Sarepta Therapeutics TTM net income year-on-year change?
Over the past year, SRPT TTM net profit has changed by +$657.82 M (+122.73%)